- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
임상 시험 검색 : Capecitabine Radiotherapy
총 4778 건
-
Sichuan Cancer Hospital and Research Institute모병
-
The Netherlands Cancer InstituteBorstkanker Onderzoek Groep; Dutch Cancer Society아직 모집하지 않음
-
First People's Hospital of HangzhouHangzhou Cancer Hospital모병
-
Yonsei University모병
-
Coordination Pharmaceuticals, Inc.University of Chicago모병
-
St. Jude Children's Research HospitalLance Armstrong Foundation모집하지 않고 적극적으로
-
Royal Marsden NHS Foundation TrustAstraZeneca; Cancer Research UK; RM/ICR Biomedical Research Centre모집하지 않고 적극적으로
-
Peking Union Medical College Hospital모집하지 않고 적극적으로
-
Lancashire Teaching Hospitals NHS Foundation TrustNIHR Lancashire Clinical Research Facility완전한
-
Juravinski Cancer CenterMitacs; McMaster University; Northern Ontario School of Medicine완전한
-
St. Joseph Hospital of Orange완전한
-
Royal Marsden NHS Foundation TrustImperial College Healthcare NHS Trust완전한
-
Beijing Tsinghua Chang Gung Hospital알려지지 않은
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Guangdong Provincial People's Hospital알려지지 않은
-
Juravinski Cancer CenterToronto Sunnybrook Regional Cancer Centre알려지지 않은
-
Advocate Health Care완전한
-
AHS Cancer Control Alberta완전한
-
National Institute of Diabetes and Digestive and...Mayo Clinic완전한
-
National University Hospital, SingaporeNational University, Singapore알려지지 않은
-
China Medical University, China알려지지 않은방사선 요법의 부작용 | 치명적인 결과 | Circulating Neoplastic Cells대만
-
University Hospital MuensterDeutsche Krebshilfe e.V., Bonn (Germany)완전한
-
Korean Cancer Study Group모집하지 않고 적극적으로
-
Beijing Biostar Pharmaceuticals Co., Ltd.Chengdu Biostar Pharmaceuticals완전한
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences완전한
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)완전한
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)완전한
-
Sanofi완전한유방암 | 전이호주, 캐나다, 프랑스, 이탈리아, 폴란드, 영국, 독일, 스페인, 미국, 아르헨티나, 콜롬비아, 이스라엘, 포르투갈, 루마니아, 남아프리카, 대한민국, 뉴질랜드, 체코 공화국, 칠레, 헝가리, 핀란드, 오스트리아, 슬로베니아, 브라질, 멕시코, 대만